Literature DB >> 28381382

The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population.

Shou-Wu Lee1, Teng-Yu Lee, Sheng-Shun Yang, Yen-Chun Peng, Hong-Zen Yeh, Chi-Sen Chang.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is associated with features of metabolic syndrome. The aim of this study was to investigate the association between NAFLD and metabolic syndrome in a Chinese population.
METHODS: Data from subjects were retrospectively collected from 2006 to 2009. The exclusion criteria included significant consumption of alcohol and chronic hepatitis B and C. The patients were assigned to two groups according to ultrasound findings: normal group and fatty liver group. The liver function of patients was determined by assessing serum alanine aminotransferase (ALT). Metabolic syndrome was diagnosed based on the 2005 International Diabetes Federation criteria.
RESULTS: A total of 7568 subjects were enrolled and 5736 (75.8%) and 1832 (24.2%) patients were assigned to the normal and fatty liver groups, respectively. The fatty liver group had significant male predominance (69.7% vs 56.0%), higher body mass index (mean, 26.67 vs 23.55 kg/m2) compared with the normal group. There were 441 (7.7%) and 377 (20.6%) cases with metabolic syndrome in the normal and fatty liver groups, respectively, with significant difference (P=0.001), and the subgroup of 385 cases with fatty liver and elevated ALT had higher prevalence (28.8%) of metabolic syndrome. The strongest association of an individual component of metabolic syndrome with NAFLD was hyperlipidemia (adjusted OR=2.55, 95% CI: 2.22-2.94).
CONCLUSION: The individuals with NAFLD had a higher ratio of metabolic syndrome. Hyperlipidemia had the strongest positive association with NAFLD.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28381382     DOI: 10.1016/s1499-3872(16)60132-7

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  7 in total

1.  Palm tocotrienol rich fraction with palm kernel oil supplementation prevents development of liver steatosis in high fat diet ICR mice.

Authors:  Mohd Danial Mohd Efendy Goon; Nur Izzati Zulkanain; Siti Hamimah Sheikh Abdul Kadir; Sharaniza Ab Rahim; Musalmah Mazlan; Normala Abd Latip; Mardiana Abdul Aziz; Norizal Mohd Noor
Journal:  Transl Gastroenterol Hepatol       Date:  2022-01-25

2.  Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study.

Authors:  Aruhan Yang; Xiaoxue Zhu; Lei Zhang; Yingwen Zhang; Dezhi Zhang; Meishan Jin; Junqi Niu; Huimao Zhang; Yanhua Ding; Guoyue Lv
Journal:  Hepatol Int       Date:  2022-07-12       Impact factor: 9.029

3.  Body mass index, waist circumference, and waist-to-height ratio for prediction of multiple metabolic risk factors in Chinese elderly population.

Authors:  Zhan Gu; Dong Li; Huayu He; Jianying Wang; Xiaojuan Hu; Peihua Zhang; Yanlong Hong; Baocheng Liu; Lei Zhang; Guang Ji
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

4.  Relationship between Serum 25-hydroxy-vitamin D Concentration and Risk of Metabolic Syndrome in Patients with Fatty Liver.

Authors:  Hee-Sook Lim; Tae-Hee Kim; Hae-Hyeog Lee; Soon-Kyung Kim; Bora Lee; Yoon-Hyung Park
Journal:  J Bone Metab       Date:  2017-11-30

5.  Sheng-Jiang Powder Ameliorates High Fat Diet Induced Nonalcoholic Fatty Liver Disease via Inhibiting Activation of Akt/mTOR/S6 Pathway in Rats.

Authors:  Juan Li; Lv Zhu; Yu-Mei Zhang; Huan Chen; Yi-Fan Miao; Hong-Xin Kang; Hong-Yu Ren; Mei-Hua Wan; Dan Long; Wen-Fu Tang
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-04       Impact factor: 2.629

6.  Abelmoschus esculentus subfractions ameliorate hepatic lipogenesis and lipid uptake via regulating dipeptidyl peptidase-4-With improving insulin resistance.

Authors:  Chiung-Huei Peng; Yaw-Bee Ker; Hsin-Hua Li; Sing-Hua Tsou; Chih-Li Lin; Chien-Ning Huang
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.240

7.  Measurement of the Combined Levels of Serum Uric Acid and Alanine Aminotransferase and the Risk of Metabolic Syndrome in a Population Aged 60 Years or More in Northeastern China.

Authors:  Jiabei Wang; Yingfang Wang; Feng Chen; Guojing Ma; Difei Wang
Journal:  Med Sci Monit       Date:  2020-01-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.